CHR-2845

· Chroma Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHR-2845, covering 2011-11-28 to 2011-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies [Phase 1]